Corindus Vascular Robotics has announced that J Aaron Grantham, an interventional cardiologist specialising in the treatment of chronic total occlusions, has joined the company as chief medical officer.
According to a company release, Grantham will be spearheading Corindus’ initiatives to educate the interventional cardiology community on the benefits of robotic therapy and will be leading efforts to develop clinical data to advance the CorPath System’s applicability for additional clinical indications. As a practicing chief medical officer, Grantham will continue treating patients at Saint Luke’s Mid America Heart Institute (Kansas City, USA).
Grantham says, “I believe that through a systematic, program-based approach, similar to my work in building chronic total occlusion programs, robotic therapy will be able to reach its full potential. I look forward to working with leaders in the field of interventional cardiology as we continue to optimise robotic therapy.”
Grantham is with Saint Luke’s Mid America Heart Institute, a member of Saint Luke’s Health system, as associate professor, University of Missouri-Kansas City School of Medicine. He also is director of the school’s Cardiovascular Disease Fellowship Program and Director of Cardiovascular Medical Education at Saint Luke’s Hospital.